SlideShare une entreprise Scribd logo
  • Mettre en ligne
  • Accueil
  • Explorer
  • S’identifier
  • S’inscrire
SlideShare une entreprise Scribd logo
  • Accueil
  • Explorer
  • Mettre en ligne
  • S’identifier
  • S’inscrire

Nous avons mis à jour notre politique de confidentialité. Cliquez ici pour consulter les détails. Cliquez ici pour consulter les détails.

×
×
×
×
×
×
Novosanis

Novosanis

8 Abonné
16 SlideShares 0 Clipboards 8 Abonné 2 Suivis
  • Débloquer l’utilisateur Bloquer l’utilisateur
16 SlideShares 0 Clipboards 8 Abonné 2 Suivis

Personal Information
Entreprise/Lieu de travail
Antwerp Belgium
Secteur d’activité
Medical / Health Care / Pharmaceuticals
Site Web
www.novosanis.com
À propos
Novosanis is a Belgian, award-winning, innovative developer. ISO13485 certified producer of medical devices adding value to the accuracy of diagnostics tests, drug delivery and overall patient’s comfort. Novosanis is active in the field of infectious diseases and oncology in the areas of prevention, detection and treatment. We have two device platforms in portfolio: VAX-ID™ is a patented and proven platform of injection devices suited for accurate drug delivery in the dermal layer of the skin. Colli-Pee™ is a patented and CE-marked sampling device suited for standardized and guaranteed collection of first-void urine for improved detection of infectious diseases and cancer.
Coordonnées
Mots-clés
innovation medical devices medical device vaccine design healthcare vaccination urine sampling intradermal vax-id colli-pee
Tout plus
Documents (16)
Tout voir
Novosanis bio japan2013_jp
il y a 9 ans • 647 Vues
Performance of a new first-void urine collection device
il y a 7 ans • 1213 Vues
HPV DNA detection in urine: Effect of a first-void urine collection device and time of collection
il y a 7 ans • 1108 Vues
The detection of hrHPV-infection of the cervix using first-void urine in women with an abnormal pap-smear
il y a 7 ans • 783 Vues
Performance of an Automated HPV Genotyping Assay using First Void Urine Specimens
il y a 7 ans • 1078 Vues
High Frequency ultrasound to assess skin thickness in healthy adults to determine maximum penetration depth and needle characteristics
il y a 7 ans • 399 Vues
Microbiological evaluation of Medical grade PP in the development of a midstream collector
il y a 5 ans • 76 Vues
Computational Modeling for the Design Optimization of a Positive Air Pressure Cleanroom
il y a 5 ans • 116 Vues
Colli-Pee: a new device to collect first-void urina at home for molecular detection of STIs
il y a 5 ans • 494 Vues
Research into dose sparing potential of VAX-ID
il y a 4 ans • 66 Vues
Evaluation of injection forces of VAX-ID to maximize usability, minimize pain & cell death
il y a 4 ans • 98 Vues
Shear Stress Test for the Determination of the Optimal Needle Diameter for Injection of Dendritic Cells
il y a 4 ans • 177 Vues
Intradermal drug delivery: human, medical and design factors
il y a 4 ans • 239 Vues
HF-Ultrasound to assess skin thickness and accuracy of penetration depth of VAX-ID
il y a 4 ans • 76 Vues
Assessment of acceptability and usability of new delivery prototype device for intradermal vaccina!on in healthy subjects
il y a 4 ans • 1037 Vues
Immunogenicity and Safety of HepatitisB Injection in the Dermis Using VAX-ID
il y a 4 ans • 4624 Vues
  • Activité
  • À propos

Documents (16)
Tout voir
Novosanis bio japan2013_jp
il y a 9 ans • 647 Vues
Performance of a new first-void urine collection device
il y a 7 ans • 1213 Vues
HPV DNA detection in urine: Effect of a first-void urine collection device and time of collection
il y a 7 ans • 1108 Vues
The detection of hrHPV-infection of the cervix using first-void urine in women with an abnormal pap-smear
il y a 7 ans • 783 Vues
Performance of an Automated HPV Genotyping Assay using First Void Urine Specimens
il y a 7 ans • 1078 Vues
High Frequency ultrasound to assess skin thickness in healthy adults to determine maximum penetration depth and needle characteristics
il y a 7 ans • 399 Vues
Microbiological evaluation of Medical grade PP in the development of a midstream collector
il y a 5 ans • 76 Vues
Computational Modeling for the Design Optimization of a Positive Air Pressure Cleanroom
il y a 5 ans • 116 Vues
Colli-Pee: a new device to collect first-void urina at home for molecular detection of STIs
il y a 5 ans • 494 Vues
Research into dose sparing potential of VAX-ID
il y a 4 ans • 66 Vues
Evaluation of injection forces of VAX-ID to maximize usability, minimize pain & cell death
il y a 4 ans • 98 Vues
Shear Stress Test for the Determination of the Optimal Needle Diameter for Injection of Dendritic Cells
il y a 4 ans • 177 Vues
Intradermal drug delivery: human, medical and design factors
il y a 4 ans • 239 Vues
HF-Ultrasound to assess skin thickness and accuracy of penetration depth of VAX-ID
il y a 4 ans • 76 Vues
Assessment of acceptability and usability of new delivery prototype device for intradermal vaccina!on in healthy subjects
il y a 4 ans • 1037 Vues
Immunogenicity and Safety of HepatitisB Injection in the Dermis Using VAX-ID
il y a 4 ans • 4624 Vues
Personal Information
Entreprise/Lieu de travail
Antwerp Belgium
Secteur d’activité
Medical / Health Care / Pharmaceuticals
Site Web
www.novosanis.com
À propos
Novosanis is a Belgian, award-winning, innovative developer. ISO13485 certified producer of medical devices adding value to the accuracy of diagnostics tests, drug delivery and overall patient’s comfort. Novosanis is active in the field of infectious diseases and oncology in the areas of prevention, detection and treatment. We have two device platforms in portfolio: VAX-ID™ is a patented and proven platform of injection devices suited for accurate drug delivery in the dermal layer of the skin. Colli-Pee™ is a patented and CE-marked sampling device suited for standardized and guaranteed collection of first-void urine for improved detection of infectious diseases and cancer.
Coordonnées
Mots-clés
innovation medical devices medical device vaccine design healthcare vaccination urine sampling intradermal vax-id colli-pee
Tout plus

Modal header

  • À propos
  • Assistance clientèle
  • Conditions générales
  • Confidentialité
  • Droits d’auteur
  • Préférences en matière de cookies
  • Ne pas vendre ou partager mes informations personnelles
Français
English
Español
Português
Langue courante: Français
Deutsch

© 2023 SlideShare from Scribd

Nous avons mis à jour notre politique de confidentialité.

Nous avons mis à jour notre politique de confidentialité pour nous conformer à l'évolution des réglementations mondiales en matière de confidentialité et pour vous informer de la manière dont nous utilisons vos données de façon limitée.

Vous pouvez consulter les détails ci-dessous. En cliquant sur Accepter, vous acceptez la politique de confidentialité mise à jour.

Merci!

Afficher la politique de confidentialité mise à jour
Nous avons rencontré un problème, veuillez réessayer.